SEOUL, Jan 25 (Reuters): Drugmaker Pfizer Inc has filed an application seeking approval of its coronavirus vaccines to be used in South Korea as the country gears up to begin inoculations next month, authorities said on Monday.
The Ministry of Food and Drug Safety said it aims to reach a decision within 40 days after cutting its previous deliberation period of up to 180 days to fast-track the approval and speed up the vaccination process.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!